Founded in 1990, Neopharm is a leading full service analytical testing laboratory serving the global pharmaceutical industry as well as natural health products, medical marijuana, veterinary and cosmetics markets. From our government-accredited operations, we provide unique quality control and consulting services, as well as perform a wide variety of analysis, including fine chemistry, microbiology, sterility testing, method development and validation, technology transfer, and stability studies. Over the years, Neopharm has successfully developed/validated/transferred in excess of 3,000 analytical procedures.
As a Health Canada certified laboratory, Neopharm benefits from Canada’s unique profile as a participant to the Global Mutual Recognition Agreements (MRA’s), covering drug/medicinal products Good Manufacturing Practice (GMP) Compliance Program, with parties such as the European Community (EC), the European Economic Area – European Free Trade Association (EEA EFTA), as well as Switzerland and Australia. Countries where MRA’s are in place will accept Certificates of Analysis (CofA’s) produced by Neopharm for the local commercialization of foreign products.